Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO14109-T1

Drug Field of development:

Neuropathic Pain Therapy Area:

Target Type of patent:

Lipid antisens oligonucleotide targeting fxyd2 as a therapeutic agent

The present invention relates to an inhibitor of FXYD2 gene expression for use in a method for treating neuropathic pain in a patient in need thereof. […]

BIO18544-T1

Drug Field of development:

Central Nervous System Therapy Area:

Target Type of patent:

Trpv2 as a new therapeutic target to modulate blood brain barrier

The present invention relates to a method for modulating blood-brain barrier (BBB) in a subject comprising a step of administering said subject with a […]

BIO15148-T1

Drug Field of development:

Ophtalmology Therapy Area:

Target Type of patent:

Modulator of wip1 levels to treat wolfram syndrome

The present invention relates to novel therapeutic ways for treating Wolfram Syndrome (WS) by targeting the neuronal calcium sensor 1 (NCS1). The […]

BIO14117-T1

Drug Field of development:

Leukemias Therapy Area:

Target Type of patent:

Cdc25a phosphatase inhibitor for use in thetreatment of a drug

The invention relates to a CDC25A phosphatase inhibitor for use in the treatment of drug resistant cancer or for use in the prevention of tumor […]

BIO11315-T1

Drug Field of development:

Musculoskeletal Therapy Area:

Target Type of patent:

Apelin analogs for the treatment of dysfunction associated with aging

The inventors show that apelin plays a role in energy metabolism and particularly in energetic mechanisms in mitochondria. They show that apelin […]

BIO17200-T1

Drug Field of development:

Chronic pain Therapy Area:

Target Type of patent:

Trek1/trek2 as targets for the treatment of migraine

Inventors have found that the MT mutation puts an alternative start codon in frame which leads to the translation of a second TRESK fragment. […]

BIO16167-T1

Drug Field of development:

Women health Therapy Area:

Target Type of patent:

A microrna switch regulates the rise in hypothalamic gnrh production

A method for diagnosing a reproduction-related disorder in an individual, comprising: a) measuring the level of a miR200 nucleic acid and/or miR155 […]

BIO22283-D1

Biomarker Field of development:

Lymphoma Therapy Area:

Method Type of patent:

Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas

The present study of the regulatory T phenotype of Sézary cells led to the discovery of the expression of LRRC33 by Sézary cells. LRRC33 therefore […]

BIO22282-D1

Biomarker Field of development:

Lymphoma Therapy Area:

Method Type of patent:

Garp as a biomarker and biotarget in t-cell malignancies

The present study of the regulatory T phenotype of Sézary cells led to the discovery of the expression of GARP (LRRC32) by Sézary cells. GARP has […]

BIO22280-D1

Biomarker Field of development:

Leukemias Therapy Area:

Method Type of patent:

Methods for the diagnosis and treatment of acute lymphoblastic

The present invention relates to a method of treating acute lymphoblastic leukemia in a patient in need thereof comprising administering to the […]

147

56

310

46

Our Technology Offers

Lipid antisens oligonucleotide targeting fxyd2 as a therapeutic agent

Trpv2 as a new therapeutic target to modulate blood brain barrier

Modulator of wip1 levels to treat wolfram syndrome

Cdc25a phosphatase inhibitor for use in thetreatment of a drug

Apelin analogs for the treatment of dysfunction associated with aging

Trek1/trek2 as targets for the treatment of migraine

A microrna switch regulates the rise in hypothalamic gnrh production

Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas

Garp as a biomarker and biotarget in t-cell malignancies

Methods for the diagnosis and treatment of acute lymphoblastic

You might also be interested in

Improved vector for driving the targeted

Nanoparticle based glue, biocompatible sealant for

Ex vivo gene therapy based vaccine with nucleic

Ctip fusion to cas9 enhances transgene integration

Trpv2 as a new therapeutic target to modulate

Lipid antisens oligonucleotide targeting fxyd2 as

Anti-kit mab for the treatment of cancer (aml,

New molecules for neurodegenerative pathologies :

Anti notch3 antibody for cadasil treatment

Lipopeptide compound for the treatment of pain

Gene therapy coding for anti-tau nanobody to treat

Targeting myeloperoxidase overcomes cytarabine